Before FSK circulated its Q4 report, I issued a bearish piece, realizing my 27% returns and suggesting investors to avoid the investment. Since then the share price has increased by 5%, but the underlying fundamentals have become worse. Plus, Q4 was a miss. In this article I explain in more details why I still recommend investors to think twice before deploying capital in FSK stock.
Assura Group (LSE:AGR) told investors it "would be minded" to accept a £1.6 billion takeover bid from KKR and Stonepeak Partners. Having rejected several previous offers, the board of the UK healthcare property investor said the consortium has now upped its bid to a potential cash offer of 49.4p per share.
British healthcare real estate investment trust Assura on Monday said it will likely consider a 1.61 billion pounds ($2.08 billion) offer from KKR and Stonepeak Partners, after rejecting four previous offers from another KKR-led consortium.
KKR shares have dropped over 25% in 2025, but are still up 21% from last year due to strong financial results. KKR's issuance of mandatory convertible preferred shares aims to raise $1.5 billion, diluting shareholders by about 1% to invest in Strategic Holdings. Strategic Holdings' aggressive growth targets add complexity and potential volatility to KKR's earnings, raising concerns among investors.
Henry McVey, KKR head of the global macro, balance sheet and risk teams, joins 'The Exchange' to discuss the facts on tariffs, where businesses are moving production, and if the market's reaction makes sense.
FS KKR Capital is downgraded to a hold due to declining NAV, weakening net investment income, and a shrinking total asset value. FSK's portfolio strategy includes a diverse $13.5B portfolio with 63.8% in senior secured debt, benefiting from high-interest rates. Although non-accruals haven't substantially increased, we can see an uptick in PIK interest income.
Britain's Thames Water has asked KKR and Castle Water to provide more detail on their equity bids, Bloomberg News reported on Tuesday, citing people familiar with the matter.
KKR & Co , Fountainvest Partners and PAG are among buyout firms interested in acquiring a stake in Starbucks' China business, four sources said, as the U.S. coffee chain looks to revive flagging sales in its second-largest market.
KKR Real Estate Finance is up 22% over the last year, now trading at a 24% discount to book value with a 9% dividend yield. KREF held $105 million in cash and cash equivalents with available liquidity at $685 million at the end of its fiscal 2024 fourth quarter. The mREIT is shifting its focus to a more aggressive loan origination stance to drive growth in 2025.
KKR has announced an agreement with leading Swedish developers Reliwe and The Derome Group to purchase three multi-family properties currently under development in Haninge, located just south of downtown Stockholm. These are three new properties totaling 382 residential units, scheduled for completion between late 2026 and early 2027. The properties are located next to a bus and train station, offering excellent connectivity to downtown Stockholm. ' We are delighted to be making our first residential investment in Stockholm, which is an attractive market where we are seeing strong momentum towards our goal of building a portfolio of residential units by teaming up with leading partners such as Reliwe and Derome,' said Alexander Thams, head of Nordic real estate for KKR. With Stockholm's strong residential market fundamentals and innovative use of wood construction, we see significant potential to create value for our investors while making a positive contribution to the community.Copyright (c) 2025 CercleFinance.com. All rights reserved.
U.S. private equity firm KKR has secured a 57.92% stake in Fuji Soft after the second stage of its tender offer bid, ending a fierce battle with rival Bain Capital to take the Japanese software developer private.
Assura Group (LSE:AGR) has confirmed what the market already knew, that it rejected a fourth takeover offer from US private equity firm KKR. The board of the healthcare focused real estate investment trust said the most recent cash offer, priced at 48p per share, had been considered "carefully" with its advisers and together they concluded it "materially undervalued the company and its prospects".